WENDY CLIFTON: Open Payments
NPI 1235284456 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 38 payments from 16 companies in 2025. Trend: 2023 $876 · 2024 $677 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| Astellas Pharma US Inc | 3 | $57 |
| PFIZER INC. | 2 | $31 |
| ABBVIE INC. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $20 |
Products named: MOUNJARO, GEMTESA, REXULTI, Veozah, JARDIANCE, AUSTEDO XR, ISTURISA, Heplisav-B.
Industry payments across NE — which companies pay providers there.
